![Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-021-00758-x/MediaObjects/13550_2021_758_Fig1_HTML.jpg "Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism | EJNMMI Research | Full Text")
Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism | EJNMMI Research | Full Text
18F-DOPA PET/TC para el diagnóstico del hiperinsulinismo congénito | Revista Argentina de Radiología
SciELO - Brasil - FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the
Reference ID: 4504654
![Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas | ADC Fetal & Neonatal Edition](https://fn.bmj.com/content/fetalneonatal/93/2/F166/F1.large.jpg?width=800&height=600&carousel=1 "Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas | ADC Fetal & Neonatal Edition")
Congenital hyperinsulinism: [18F]DOPA PET/CT scan of a focal lesion in the head of the pancreas | ADC Fetal & Neonatal Edition
![18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study](https://article.imrpress.com/journal/JIN/19/3/10.31083/j.jin.2020.03.196/1757-448X-19-3-489/fig2.jpg "18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study")
18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study
![Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04963-z/MediaObjects/259_2020_4963_Figa_HTML.png "Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma | SpringerLink")
Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma | SpringerLink
![Incidental meningioma detected with [18F]-FDOPA PET/CT | European Journal of Hybrid Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41824-018-0041-3/MediaObjects/41824_2018_41_Fig2_HTML.png "Incidental meningioma detected with [18F]-FDOPA PET/CT | European Journal of Hybrid Imaging | Full Text")
Incidental meningioma detected with [18F]-FDOPA PET/CT | European Journal of Hybrid Imaging | Full Text
Negative 18 F-DOPA PET scan in a patient suspected of having PD. The... | Download Scientific Diagram
![Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure | Neurology](https://n.neurology.org/content/neurology/76/15/1296/F2.large.jpg "Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure | Neurology")
Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure | Neurology
Diagnostic Value of Early F-18-FDOPA PET-CT for Initial Staging of Neuroblastoma: A Comparison Study with Delay F-18-FDOPA PET-CT and I-123-MIBG Scintigraphy/SPECT-CT | Journal of Nuclear Medicine
68Ga-DOTANOC and 18F-DOPA PET/CT: a site-specific approach to the imaging of parangliomas of the head and neck and of the abdomen | SpringerLink
18F-FDOPA PET/CT scan of the patient illustrated in Fig 2.
Fluorodopa FDOPA (F18 Injection): Uses, Dosage, Side Effects, Interactions, Warning
Molecular imaging of movement disorders
18F-DOPA PET/TC para el diagnóstico del hiperinsulinismo congénito | Revista Argentina de Radiología
![Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/27/30/8080/F1.large.jpg "Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study | Journal of Neuroscience")
Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study | Journal of Neuroscience
The sensitivity and specificity of F-DOPA PET in a movement disorder clinic. | Semantic Scholar
Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism | PLOS ONE
18 F-dopa PET scans in age-matched controls and study patients with... | Download Scientific Diagram
IJMS | Free Full-Text | Beyond Visual Assessment of Basal Ganglia Uptake: Can Automated Method and Pineal Body Uptake Assessment Improve Identification of Nigrostriatal Dysfunction on 18F-DOPA PET/CT?
18F-FDOPA: A Multiple-Target Molecule | Journal of Nuclear Medicine
Myocardial Metastases on 6-[18F] fluoro-L-DOPA PET/CT: A Retrospective Analysis of 116 Serotonin Producing Neuroendocrine Tumour Patients | PLOS ONE
Role of 18F‐FDOPA PET/CT imaging in endocrinology - Santhanam - 2014 - Clinical Endocrinology - Wiley Online Library
18 F-Dopa PET in a healthy volunteer (normal); in a subject with... | Download Scientific Diagram
![Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/27/30/8080/F3.large.jpg "Elevated [18F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [18F]Fluorodopa/Positron Emission Tomography Study | Journal of Neuroscience")